Amano Enzyme USA to Showcase Food, Beverage, and Diagnostic Enzyme Solutions at IFT FIRST and ADLM 2026

Amano Enzyme is pleased to announce its participation in two major U.S. industry events in July 2026: IFT FIRST 2026 in Chicago, Illinois, and ADLM 2026 in Anaheim, California.

At both events, Amano Enzyme will highlight how advanced enzyme technology supports practical innovation across food, beverage, functional ingredients, and diagnostic applications.

Amano Enzyme will exhibit at IFT FIRST 2026 from July 12–15 in Chicago, where the company will present enzyme solutions for food and beverage product development.

Visitors are invited to Booth 838 to explore practical application concepts and tasting samples, including high-protein plant-based nacho cheese, cold brew coffee, and oatmilk creamer. These samples demonstrate how enzyme technology can support taste, texture, functionality, and processing performance across a wide range of food and beverage applications.

Amano Enzyme will also contribute to the IFT FIRST technical program through two presentations by Hiroyuki Yachi, M.S., Senior Scientist at Amano Enzyme:

July 14, 2026 | 4:15 PM–4:35 PM
Expo Hall A, Science Live Stage 1

July 14, 2026 | 1:30 PM–4:30 PM
Exhibit Hall A, Poster Area

These sessions will address how enzyme selection and application can help solve product development and manufacturing challenges in beverage innovation, collagen peptide production, and functional ingredient development.

Following IFT FIRST, Amano Enzyme will exhibit at ADLM 2026 from July 26–30 in Anaheim, California, at Booth 3063.

At ADLM, Amano Enzyme will showcase diagnostic enzyme solutions for system monitoring applications, including blood glucose, cholesterol, and ketone monitoring. Featured enzymes will include:

Amano Enzyme will also highlight additional diagnostic enzyme applications related to triglycerides, uric acid, and bilirubin testing.

The company looks forward to engaging with diagnostic manufacturers, R&D professionals, laboratory medicine specialists, and industry partners to discuss how enzyme technologies can support reliable diagnostic system performance.

Amano Enzyme welcomes attendees to visit its teams at both events:

Through its participation in IFT FIRST and ADLM 2026, Amano Enzyme continues to demonstrate the broad potential of enzyme technology across food innovation, beverage development, functional ingredients, and diagnostic system monitoring.

Explore unlimited possibilities with Amano Enzyme.